Back to Search Start Over

Long-lasting remission in a metastatic hepatocellular carcinoma patient after combined regorafenib therapy and surgery

Authors :
Elisabetta Goio
Luca Ielasi
Francesca Benevento
Matteo Renzulli
Francesco Tovoli
Source :
Hepatic Oncology, Vol 7, Iss 3 (2020)
Publication Year :
2020
Publisher :
Taylor & Francis, 2020.

Abstract

Aims: The therapeutic scenario of systemic treatments for hepatocellular carcinoma (HCC) is rapidly changing. There is much interest in the possibility of combining new therapies with surgery, but clinical data is lacking. We aimed to provide an example of such integration. Patients & methods: We report a patient with metastatic HCC who received regorafenib in the setting of the RESORCE trial. Results: A brilliant response led to a tumor downstaging and a subsequent adrenal metastasectomy with radical intent. Conclusions: New agents will change the therapeutic perspectives in advanced HCC and lead to a higher rate of objective responses, with possibilities of associating systemic therapy and surgery. Thus, the management of HCC will require more and more of an integrated, multidisciplinary and personalized approach.

Details

Language :
English
ISSN :
20450931 and 20450923
Volume :
7
Issue :
3
Database :
Directory of Open Access Journals
Journal :
Hepatic Oncology
Publication Type :
Academic Journal
Accession number :
edsdoj.9bebd2e3c34449ee8d5d9998b37dab53
Document Type :
article
Full Text :
https://doi.org/10.2217/hep-2020-0014